CKLIFE SCIENCES<08222> - Results Announcement (Q3, 2006, Summary)


CK Life Sciences Int'l., (Holdings) Inc. announced on 13 November 2006:
(stock code: 08222 )

Year end date                         :31/12/2006
Currency                              :HKD
Auditors' report                      :N/A
3rd Quarterly Report Reviewed by      :Audit Committee

Important Note :

This result announcement form only contains extracted information from
and should be read in conjunction with the detailed results announcement
of the issuer, which can be viewed on the GEM website at
http://www.hkgem.com

                                           (Unaudited)       (Unaudited)
                                              Current Last Corresponding
                                               Period            Period
                                       from 01/01/2006   from 01/01/2005
                                         to 30/09/2006     to 30/09/2005
                                               HK$'000           HK$'000

Turnover                              :      1,502,214           485,520
Profit/(Loss) from Operations         :         74,443            19,924
Finance cost                          :       (29,303)           (7,996)
Share of Profit/(Loss) of Associates  :          (816)             4,728
Share of Profit/(Loss) of Jointly
         Controlled Entites           :            N/A               N/A
Profit/(Loss) after Taxation & MI     :         33,303             8,324
% Change Over the Last Period         :        +300.08%
EPS / (LPS)
          Basic (in dollar)           :     HKD 0.0039        HKD 0.0012
          Diluted (in dollar)         :            N/A               N/A
Extraordinary (ETD) Gain/(Loss)       :            N/A               N/A
Profit (Loss) after ETD Items         :        33,303             8,324
3rd Quarter Dividends per Share       :            NIL               NIL
(specify if with other options)       :            N/A               N/A
B/C Dates for 3rd Quarter Dividends   :            N/A
Payable Date                          :            N/A
B/C Dates for (-) General Meeting     :            N/A
Other Distribution for Current Period :            NIL
B/C Dates for Other Distribution      :            N/A
                                       (bdi: both days inclusive)

For and on behalf of
CK Life Sciences Int'l., (Holdings) Inc.

Signature :
Name      : Mo Yiu Leung, Jerry
Title     : Qualified Accountant

Responsibility statement

The directors of the Company (the "Directors") as at the date hereof
hereby collectively and individually accept full responsibility for the
accuracy of the information contained in this results announcement form
(the "Information") and confirm, having made all reasonable inquiries,
that to the best of their knowledge and belief the Information are
accurate and complete in all material respects and not misleading and
that there are no other matters the omission of which would make the
Information herein inaccurate or misleading.The Directors acknowledge
that the Stock Exchange has no responsibility whatsoever with regard to
the Information and undertake to indemnify the Exchange against all
liability incurred and all losses suffered by the Exchange in connection
with or relating to the Information.

Remarks:
	
1. Basis of preparation
	
The unaudited consolidated results of the Group have been
prepared in accordance with accounting principles generally
accepted in Hong Kong and the applicable disclosure requirements
of the GEM Listing Rules. They have also been prepared under
the historical cost convention,as modified for the revaluation
of certain fixed assets and financial instruments.
	
	
	
The accounting policies used in preparing the unaudited consolidated
results are consistent with those used in the Group's annual
financial statements for the year ended 31 December 2005.
	
	
2.  Earnings per share
	
The calculations of the basic and diluted earnings per share
are based on the following data:
	
                              For the nine months ended 30 September
                                     2006               2005
                                  HK$'000            HK$'000
Profit for the period
	
Profit for calculating
basic and diluted
earnings per share                 33,303              8,324
                                 =========	     ========
	
Number of shares
	
Weighted average number
of ordinary shares used
in the calculation of
basic earnings per share       8,472,670,799    7,201,896,918
                               =============    ==============
	
	
The weighted average number of ordinary shares used in the
calculation of earnings per share for the nine months ended
30 September 2006 has accounted for the issuance of new shares
pursuant to the rights issue which was completed on 10 May 2006.
The corresponding number of ordinary shares for 2005 has
been retrospectively adjusted to reflect the said rights issue.
	
No diluted earnings per share is presented for the nine months
ended 30 September 2006 because there were no dilutive potential
ordinary shares in existence during the relevant periods.